Chengkai Xu

448 total citations
11 papers, 361 citations indexed

About

Chengkai Xu is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Chengkai Xu has authored 11 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Chengkai Xu's work include Cancer-related molecular mechanisms research (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (2 papers). Chengkai Xu is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (2 papers). Chengkai Xu collaborates with scholars based in China and United States. Chengkai Xu's co-authors include Danli Kong, Kai Wang, Yuanlin Ding, Juanjuan Lin, Taek‐Kyun Kim, Mingyuan Huang, Alton Etheridge, Yuqing He, Yanhong Luo and Mi Lin and has published in prestigious journals such as International Journal of Cancer, Clinical Chemistry and Gene.

In The Last Decade

Chengkai Xu

11 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chengkai Xu China	6	271	256	32	26	17	11	361
Chong Guo China	10	221 0.8×	218 0.9×	27 0.8×	24 0.9×	18 1.1×	22	314
Yunhui Qu China	9	235 0.9×	200 0.8×	33 1.0×	30 1.2×	28 1.6×	18	317
Sushmaa Chandralekha Selvakumar India	8	279 1.0×	199 0.8×	12 0.4×	37 1.4×	16 0.9×	18	374
Guokai Pan China	8	335 1.2×	250 1.0×	27 0.8×	49 1.9×	39 2.3×	10	432
Yuefeng Li China	9	310 1.1×	264 1.0×	26 0.8×	23 0.9×	9 0.5×	12	376
Jieyu Zhou China	11	219 0.8×	184 0.7×	23 0.7×	24 0.9×	19 1.1×	19	302
Jiaxiang Ye China	12	230 0.8×	167 0.7×	47 1.5×	64 2.5×	27 1.6×	27	350
Zhongxun Li China	8	161 0.6×	103 0.4×	23 0.7×	19 0.7×	16 0.9×	12	268
Ke-Xin Tang China	8	190 0.7×	95 0.4×	24 0.8×	18 0.7×	17 1.0×	20	289
Chenbin Chen China	8	289 1.1×	207 0.8×	15 0.5×	53 2.0×	25 1.5×	20	366

Countries citing papers authored by Chengkai Xu

Since Specialization

Citations

This map shows the geographic impact of Chengkai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengkai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengkai Xu more than expected).

Fields of papers citing papers by Chengkai Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengkai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengkai Xu. The network helps show where Chengkai Xu may publish in the future.

Co-authorship network of co-authors of Chengkai Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengkai Xu. A scholar is included among the top collaborators of Chengkai Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengkai Xu. Chengkai Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Zhang, Zhengwei, et al.. (2023). PP2Ac knockdown attenuates lipotoxicity‑induced pancreatic β‑cell dysfunction and apoptosis. Experimental and Therapeutic Medicine. 26(6). 549–549. 1 indexed citations

Xu, Chengkai, et al.. (2022). Pyroptosis Patterns Are Involved in Immune Microenvironment Regulation of Dilated Cardiomyopathy. Disease Markers. 2022. 1–15. 5 indexed citations

Xu, Chengkai, et al.. (2022). Association between Circulating Antioxidants and Longevity: Insight from Mendelian Randomization Study. BioMed Research International. 2022(1). 4012603–4012603. 7 indexed citations

Wang, Kexin, et al.. (2022). Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq. BMC Cardiovascular Disorders. 22(1). 320–320. 6 indexed citations

Xu, Chengkai, et al.. (2022). Causal effect of iron status on lung function: A Mendelian randomization study. Frontiers in Nutrition. 9. 1025212–1025212. 4 indexed citations

Zhang, Meiting, et al.. (2019). GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway. Experimental Cell Research. 381(1). 1–9. 48 indexed citations

Xu, Chengkai, et al.. (2018). Comparative study of thyroid hormone and antithyroid antibody levels in patients with gestational diabetes mellitus and pregnant patients with diabetes. Minerva Endocrinology. 43(2). 126–130. 5 indexed citations

Xu, Chengkai, et al.. (2017). Ganodermanontriol inhibits expression of special AT rich sequence binding protein 1 gene in human hepatocellular carcinoma. Journal of Cancer Research and Therapeutics. 14(12). 964–964. 5 indexed citations

He, Yuqing, Juanjuan Lin, Yuanlin Ding, et al.. (2015). A systematic study on dysregulated microRNAs in cervical cancer development. International Journal of Cancer. 138(6). 1312–1327. 73 indexed citations

10.

Yang, Jie, Danli Kong, Juanjuan Lin, et al.. (2015). Association of miR-146a rs2910164 polymorphism with cardio-cerebrovascular diseases: A systematic review and meta-analysis. Gene. 565(2). 171–179. 12 indexed citations

11.

He, Yuqing, Juanjuan Lin, Danli Kong, et al.. (2015). Current State of Circulating MicroRNAs as Cancer Biomarkers. Clinical Chemistry. 61(9). 1138–1155. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact